Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases

Caffeine is the major component of coffee and the most consumed psychostimulant in the world and at nontoxic doses acts as a nonselective adenosine receptor antagonist. Epidemiological evidence suggests that caffeine consumption reduces the risk of several neurological and neurodegenerative diseases...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria H. Madeira, Raquel Boia, António F. Ambrósio, Ana R. Santiago
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2017/4761081
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552976106913792
author Maria H. Madeira
Raquel Boia
António F. Ambrósio
Ana R. Santiago
author_facet Maria H. Madeira
Raquel Boia
António F. Ambrósio
Ana R. Santiago
author_sort Maria H. Madeira
collection DOAJ
description Caffeine is the major component of coffee and the most consumed psychostimulant in the world and at nontoxic doses acts as a nonselective adenosine receptor antagonist. Epidemiological evidence suggests that caffeine consumption reduces the risk of several neurological and neurodegenerative diseases. However, despite the beneficial effects of caffeine consumption in human health and behaviour, the mechanisms by which it impacts the pathophysiology of neurodegenerative diseases still remain to be clarified. A promising hypothesis is that caffeine controls microglia-mediated neuroinflammatory response associated with the majority of neurodegenerative conditions. Accordingly, it has been already described that the modulation of adenosine receptors, namely, the A2A receptor, affords neuroprotection through the control of microglia reactivity and neuroinflammation. In this review, we will summarize the main effects of caffeine in the modulation of neuroinflammation in neurodegenerative diseases.
format Article
id doaj-art-4696d15c52ab49be8526cba3d46c5613
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-4696d15c52ab49be8526cba3d46c56132025-02-03T05:57:11ZengWileyMediators of Inflammation0962-93511466-18612017-01-01201710.1155/2017/47610814761081Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative DiseasesMaria H. Madeira0Raquel Boia1António F. Ambrósio2Ana R. Santiago3Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, PortugalInstitute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, PortugalInstitute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, PortugalInstitute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, PortugalCaffeine is the major component of coffee and the most consumed psychostimulant in the world and at nontoxic doses acts as a nonselective adenosine receptor antagonist. Epidemiological evidence suggests that caffeine consumption reduces the risk of several neurological and neurodegenerative diseases. However, despite the beneficial effects of caffeine consumption in human health and behaviour, the mechanisms by which it impacts the pathophysiology of neurodegenerative diseases still remain to be clarified. A promising hypothesis is that caffeine controls microglia-mediated neuroinflammatory response associated with the majority of neurodegenerative conditions. Accordingly, it has been already described that the modulation of adenosine receptors, namely, the A2A receptor, affords neuroprotection through the control of microglia reactivity and neuroinflammation. In this review, we will summarize the main effects of caffeine in the modulation of neuroinflammation in neurodegenerative diseases.http://dx.doi.org/10.1155/2017/4761081
spellingShingle Maria H. Madeira
Raquel Boia
António F. Ambrósio
Ana R. Santiago
Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases
Mediators of Inflammation
title Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases
title_full Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases
title_fullStr Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases
title_full_unstemmed Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases
title_short Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases
title_sort having a coffee break the impact of caffeine consumption on microglia mediated inflammation in neurodegenerative diseases
url http://dx.doi.org/10.1155/2017/4761081
work_keys_str_mv AT mariahmadeira havingacoffeebreaktheimpactofcaffeineconsumptiononmicrogliamediatedinflammationinneurodegenerativediseases
AT raquelboia havingacoffeebreaktheimpactofcaffeineconsumptiononmicrogliamediatedinflammationinneurodegenerativediseases
AT antoniofambrosio havingacoffeebreaktheimpactofcaffeineconsumptiononmicrogliamediatedinflammationinneurodegenerativediseases
AT anarsantiago havingacoffeebreaktheimpactofcaffeineconsumptiononmicrogliamediatedinflammationinneurodegenerativediseases